Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ensysce Biosciences Inc (ENSC)

Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ensysce Biosciences Inc 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 USA

www.ensysce.com Employees: 10 P: 858-263-4196

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Ensysce Biosciences is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is involved in developing tamper-proof opioids which prevent both drug abuse and overdoses. Ensysce Biosciences, formerly known as Leisure Acquisition Corp., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 4,310
Enterprise Value, $K 0
Shares Outstanding, K 9,278
Float, K 9,018
% Float 97.20%
Short Interest, K 195
Short Float 2.10%
Days to Cover 1.00
Short Volume Ratio 0.48
% of Insider Shareholders 2.80%
% of Institutional Shareholders 5.63%

Financials:

Annual Sales, $ 5,070 K
Annual Net Income, $ -10,180 K
Last Quarter Sales, $ 1,880 K
Last Quarter Net Income, $ -2,770 K
EBIT, $ -10,240 K
EBITDA, $ -10,230 K

Growth:

1-Year Return -76.35%
3-Year Return -99.22%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.75 on 03/30/26
Next Earnings Date 05/12/26
Earnings Per Share ttm -4.22
EPS Growth vs. Prev Qtr 41.86%
EPS Growth vs. Prev Year 74.14%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 12/06/24

ENSC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -426.62%
Return-on-Assets % -195.53%
Profit Margin % -200.79%
Debt/Equity 0.00
Price/Sales 0.89
Price/Cash Flow N/A
Price/Book 0.77
Book Value/Share 0.63
Interest Coverage -508.00
60-Month Beta 1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.